If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPTY.L Regulatory News (PTY)

  • There is currently no data for PTY

Director/PDMR Shareholding

18 Apr 2019 11:37

RNS Number : 6520W
Parity Group PLC
18 April 2019
 

18 April 2019

 

Parity Group plc ("Parity "or the "Group")

Grant of Options to Directors/PDMRs

 

The Board of Parity (AIM:PTY), the technology focussed consultancy and staffing business announces that the Board has awarded Matthew Bayfield, Chief Executive Officer 3,000,000 ordinary shares of 2 pence each in the Company ("Share Options"). The Share Options were granted on 18 April 2019 on the recommendation of the Remuneration Committee, and represent approximately 2.9% of the Company's current issued share capital.

 

The Share Options each have an exercise price, calculated in accordance with the rules of the Unapproved CSOP Scheme 2009, of 7.75 pence being the closing mid-market price per ordinary share on 17 April 2019.

 

The Share Options will vest after 3 years and are subject to the following performance conditions:

 

· One third of the Share Options will be exercisable if the share price achieves or exceeds 125% of the exercise price for a period of at least five consecutive trading days at any time during the vesting period;

· One third of the Share Options will be exercisable if the share price achieves or exceeds 150% of the exercise price for a period of at least five consecutive trading days at any time during the vesting period; and

· One third of the Share Options will be exercisable if the share price achieves or exceeds 175% of the exercise price for a period of at least five consecutive trading days at any time during the vesting period.

 

 

 

 

Contacts:

Parity Group PLC www.parity.net

Roger Antony, GFD + 44 (0) 208 543 5353

 

WH Ireland Limited www.whirelandcb.com

Mike Coe / Chris Savidge +44 (0) 207 220 1666

 

 

The notifications below, made in accordance with the EU Market Abuse Regulation, provide further details in relation to the grant of the Share Options to the PDMRs:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Matthew Bayfield

2

 

Reason for the notification

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Parity Group plc

b)

 

LEI

213800YEHAYBJ63OHB38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 2p each

 

GB00B1235860

b)

 

Nature of the transaction

 

Grant of options to subscribe for new ordinary shares under the Company's Unapproved CSOP Scheme 2009.

c)

 

Price(s) and volume(s)

 

Option Price(s)

 

Volume(s)

7.75p

3,000,000

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

- Price

 

 

 

3,000,000

 

£232,500.00

 

e)

 

Date of the transaction

18 April 2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKFDNKBKDPQD
Date   Source Headline
1st Feb 20137:00 amRNSExecutive Director and General Counsel appointment
16th Jan 201310:40 amRNSNotification of Major Interest in Shares
10th Jan 20137:00 amRNSIssue of Equity
8th Jan 20137:00 amRNSTrading Statement
3rd Dec 201211:45 amRNSAnnual information update
1st Nov 20127:00 amRNSInterim Management Statement
21st Aug 20127:00 amRNSHalf Yearly Report
21st Jun 20124:07 pmRNSDirector/PDMR Shareholding
31st May 20127:00 amRNSAdditional Listing and Total Voting Rights
29th May 20122:52 pmRNSResult of AGM
29th May 20127:00 amRNSAcquisition
17th May 20127:00 amRNSInterim Management Statement
15th May 20124:21 pmRNSExercise of Options
4th Apr 20124:23 pmRNSGrant of options
6th Mar 20127:00 amRNSFinal Results
12th Dec 20119:12 amRNSAnnual Information Update
30th Nov 20114:18 pmRNSHolding(s) in Company
3rd Nov 20117:04 amRNSDirectorship in another plc
3rd Nov 20117:00 amRNSDirectorate Change
3rd Nov 20117:00 amRNSInterim Management Statement
16th Aug 20117:00 amRNSHalf Yearly Report
1st Aug 20119:07 amRNSDirector Declaration
30th Jun 20117:00 amRNSTotal Voting Rights
13th Jun 20113:12 pmRNSExercise of Options
8th Jun 20117:00 amRNSDirectorate Change
7th Jun 20111:04 pmRNSResult of AGM
7th Jun 201110:28 amRNSAGM Trading Update
27th May 201111:36 amRNSResult of General Meeting
26th May 20117:00 amRNSResult of Firm Placing, Placing & Open Offer
11th May 20117:00 amRNSProposed Firm Placing, Placing and Open Offer
3rd May 20112:57 pmRNSTotal Voting Rights
28th Apr 20117:00 amRNSPosting of Annual Report and Notice of AGM
8th Apr 201112:34 pmRNSHolding(s) in Company
1st Apr 201110:32 amRNSDirectorate Change
31st Mar 20113:27 pmRNSTotal Voting Rights
3rd Mar 20117:00 amRNSFinal Results
2nd Mar 20112:57 pmRNSChange of Adviser
1st Mar 20112:51 pmRNSExercise of Options
4th Jan 20117:00 amRNSBoard Change
21st Dec 20105:29 pmRNSRetirement Pension Plan
7th Dec 201012:46 pmRNSNew Asset-based lending facility
18th Nov 20109:28 amRNSInterim Management Statement
25th Oct 201012:09 pmRNSResult of Proxy Voting at EGM
25th Oct 201012:09 pmRNSResult of Proxy Voting at EGM
15th Oct 20109:07 amRNSAnnual Information Update
4th Oct 20107:00 amRNSHalf Yearly Report
29th Sep 20103:18 pmRNSAppointment of Chief Restructuring Officer
23rd Sep 201010:27 amRNSHolding(s) in Company
31st Aug 201012:59 pmRNSHalf Yearly Report
22nd Jul 20101:30 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.